News
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
13-May-2026 | 16:58
Sales rise 2.15% to Rs 995.30 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 5.70% to Rs 277.86 crore in the quarter ended March 2026 as against Rs 262.87 crore during the previous quarter ended March 2025. Sales rose 2.15% to Rs 995.30 crore in the quarter ended March 2026 as against Rs 974.37 crore during the previous quarter ended March 2025.
For the full year,net profit rose 11.69% to Rs 1035.98 crore in the year ended March 2026 as against Rs 927.58 crore during the previous year ended March 2025. Sales rose 1.93% to Rs 3821.67 crore in the year ended March 2026 as against Rs 3749.21 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 995.30 | 974.37 | 2 | 3821.67 | 3749.21 | 2 |
| OPM % | 35.26 | 34.20 | - | 34.26 | 31.40 | - |
| PBDT | 386.27 | 373.29 | 3 | 1451.83 | 1321.98 | 10 |
| PBT | 373.10 | 358.57 | 4 | 1385.39 | 1255.19 | 10 |
| NP | 277.86 | 262.87 | 6 | 1035.98 | 927.58 | 12 |
Powered by Capital Market - Live News
